Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
RXRX Recursion Pharmaceuticals
- 6.030
- -0.060-0.99%
Close Dec 20 16:00 ET
- 6.060
- +0.030+0.50%
Post 20:01 ET
2.36BMarket Cap-3.92P/E (TTM)
6.200High5.930Low19.94MVolume6.000Open6.090Pre Close120.60MTurnover5.60%Turnover RatioLossP/E (Static)390.72MShares15.74052wk High4.49P/B2.15BFloat Cap5.60052wk Low--Dividend TTM356.02MShs Float42.810Historical High--Div YieldTTM4.43%Amplitude4.540Historical Low6.048Avg Price1Lot Size
About Recursion Pharmaceuticals Company
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolRXRX
Company NameRecursion Pharmaceuticals
Listing DateApr 16, 2021
Issue Price18.00
Founded2013
CEODr. Christopher Gibson, PhD
MarketNASDAQ
Employees500
Fiscal Year Ends12-31
Address41 South Rio Grande Street
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84101
Phone1-385-269-0203
Websitehttp://www.recursion.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Gibson, PhD
- Chief Executive Officer, Director and President
- 8.61M
- Dr. David J. Mauro, M.D.
- Chief Medical Officer
- 4.31M
- Dr. Najat Khan, PhD
- Director, Chief Research and Development Officer and Chief Commercial Officer
- --
- David Hallett, PhD
- Chief Scientific Officer
- --
- Matthew Kinn
- Chief Business Officer
- --
- Kristen Rushton
- Chief Operating Officer
- --
- Ben R. Taylor
- Chief Financial Officer and President, Recursion UK
- --
- Lina Nilsson
- Senior Vice President and Head, Platform
- --
- Dr. Robert M. Hershberg, M.D.,PhD
- Chairman of the Board
- 302.74K
- Dr. Franziska Michor, PhD
- Director
- --
- Zachary Bogue, J.D.
- Independent Director
- 21.25K
- Zavain Dar, PhD
- Independent Director
- 307.74K
- Dean Y. Li, M.D.,PhD
- Independent Director
- 300.25K
- Dr. Blake Borgeson, PhD
- Independent Director
- 292.74K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
